BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a next-generation blood separation technology that is ...

Liquid biopsies have emerged as a powerful tool in modern medicine, enabling non-invasive detection and monitoring of diseases such as cancer. At the forefront of this revolution are the BD PAXgene ® ...

The BD P800™ Blood Collection System stands at the forefront of metabolic research, particularly in the context of obesity. Its unique ability to stabilize critical plasma markers has revolutionized ...

The selection and design of blood collection tubes have emerged as critical factors in clinical chemistry, influencing both the integrity of analytes and the efficiency of laboratory workflows. Modern ...

A prolonged stay in a hospital can be taxing even without repeated blood draws to monitor a person’s condition. BD hopes to make that part of the process a little easier, through the acquisition of ...